Navigation Links
Rescheduling of First NuvaRing Lawsuit Trials in State, Federal NuvaRing Lawsuit Litigation, Reports Wright & Schulte LLC
Date:4/15/2013

Columbus, OH (PRWEB) April 15, 2013

Wright & Schulte LLC, an experienced defective medical device injury law firm representing numerous women in NuvaRing lawsuit s, notes that the first trials in state and federal NuvaRing litigation s have been rescheduled. According to a Case Management Order dated March 5th, the first trial in hundreds of NuvaRing lawsuits currently pending in New Jersey Superior Court, Bergen County, has been postponed until June 17, 2013. (Docket No. BER-L-3081-09 MT) Meanwhile, court documents indicate that the Judge overseeing NuvaRing lawsuit claims in a multidistrict litigation underway in U.S. District Court, Eastern District of Missouri, has rescheduled that litigation’s first trial for October 2013. (In re NuvaRing Products Liability Litigation, No. 4:08MD1964 [E.D. Mo.])

NuvaRing side effect lawsuit s pending in both litigations allege the birth control device caused serious, life-threatening injuries, including pulmonary emboli, deep vein thrombosis, heart attacks, blood clots and stroke. According to court records, more than 200 NuvaRing lawsuit s are pending in New Jersey Superior Court, while more than 1,000 have been filed in the Eastern District of New Jersey.

NuvaRing was the first and only once-a-month vaginal birth control ring, and is touted as having the same efficacy as birth control pills or the patch in preventing pregnancy, but with more convenience. The product’s labeling states that the vaginal ring is expected to be associated with similar risks to that of birth control pills. However, Plaintiffs in NuvaRing lawsuits allege that NuvaRing actually poses higher risks than those associated with oral contraceptives. They further accuse the Defendants of concealing information regarding the increased risk of thrombotic events posed by the contraceptive device.
[judiciary.state.nj.us/mass-tort/nuvaring/index.htm]

According to a study published by the U.S. Food & Drug Administration (FDA) in 2011, NuvaRing raised the risk of blood clots, including deep vein thrombosis and pulmonary embolism, by 56% when compared to older birth control pills. Last summer, two additional studies published in The New England Journal of Medicine and the British Medical Journal indicated that users of NuvaRing faced a higher risk of suffering dangerous blood clots, as well as heart attacks and strokes.
[http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
[http://www.bmj.com/content/344/bmj.e2990
[http://www.nejm.org/doi/full/10.1056/NEJMoa1111840?query=featured_home

Data from the FDA indicates that NuvaRing has been named a suspect in more than 5,400 reports made to the agency’s Adverse Events Database, More than 1,200 of those reports involved pulmonary embolism, while another 800 involved cases of deep vein thrombosis. Just over 160 of the NuvaRing adverse events reported to the FDA involved a death, while another 300 were deemed life-threatening.
[http://www.adverseevents.com/drugdetail.php?AEDrugID=4584&BrandName=NUVARING

Wright & Schulte LLC offers free NuvaRing lawsuit evaluations to victims of NuvaRing side effects. If you or someone you love suffered a blood clot, pulmonary embolism, deep vein thrombosis, heart attack, stroke or sudden death while using NuvaRing, please visit yourlegalhelp.com, or call toll-FREE 1-800-399-0795 to learn more about your options for legal recourse.

About Wright & Schulte LLC
Wright & Schulte LLC, a leading personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged, and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free case evaluations are available through yourlegalhelp.com, or call 1-800-399-0795

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795

Read the full story at http://www.prweb.com/releases/2013/4/prweb10575559.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Top Miami Online Marketing Company OptFirst To Launch A New Online Marketing Platform
2. John Theurer Cancer Center hosts first Womens Oncology Conference
3. Dr. Benjamin Stong is the First Facial Plastic and Reconstructive Surgeon to Display the ABFPRS Board Certification Diplomate Logo
4. Enrollment First, Inc. and First Staff Benefits Guide Businesses Through Maze of Health Care Reform
5. For First Time, Pain Signature Spotted on Brain MRIs
6. T cell biology pioneer Allison wins first AACR honor for cancer immunology
7. Baptist Health South: First US Hospital Network to Receive Full Accreditation from ACE
8. ASH awards first Bridge Grants to sustain critical hematology research
9. First Vaginal Mesh Lawsuit Trials in Federal C.R. Bard Avaulta Mesh Litigation To Begin, Reports Wright & Schulte LLC
10. CHOP oncologist leads first SU2C pediatric dream team
11. Medistra Hospital, Jakarta Becomes First Hospital in Indonesia with Centralized Image Archive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... ... solutions for drugs, biologics and consumer health products, today announced that two of ... validation of bioassays at two upcoming conferences. , At the BEBPA 10th Annual ...
(Date:9/25/2017)... , ... September 25, 2017 , ... ... affiliated with NCPDP, announced today that it has awarded a $40,000 grant to ... NCPDP’s SCRIPT Standard for ePrescribing. CancelRx enables prescribers to electronically cancel a prescription ...
(Date:9/25/2017)... ... September 25, 2017 , ... Lean Management techniques ... principle of First-Defect-Stop for laboratory weighing is designed to help laboratory ... to have negative consequences on downstream processes. , If a problem is detected, ...
(Date:9/25/2017)... ... September 25, 2017 , ... Bioclinica®, ... today announces that 30 of its domain experts will present on a ... upcoming industry conferences and webinars. Drawing on broad and deep industry experience ...
(Date:9/25/2017)... , ... September 25, 2017 , ... ... retirement is not an option to senior, upper-level executives speaking at a business ... , "A senior, high-level executive is an asset to be fully realized and ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... KALAMAZOO, Mich. , Sept. 18, 2017  PMD ... OptiMed Specialty Pharmacy of Kalamazoo, Mich. ... strategic hub service that expedites and streamlines patient and ... Spiro PD 2.0, and wellness management services.  ... medical device used to measure lung function for a ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
Breaking Medicine Technology: